Gross Anatomy: Snake Bites Penis
(MedPage Today) -- Man's penis gets bit by a viper (Source: MedPage Today Urology)
Source: MedPage Today Urology - September 11, 2015 Category: Urology & Nephrology Source Type: news
Prostate Cancer: Optimism, Caution for Active Surveillance (CME/CE)
(MedPage Today) -- Two-thirds of prostate cancer patients qualify--with caveats (Source: MedPage Today Urology)
Source: MedPage Today Urology - August 20, 2015 Category: Urology & Nephrology Source Type: news
Suicidal Ideation Higher for Cancer Survivors (CME/CE)
(MedPage Today) -- Risk seen even in absence of depression (Source: MedPage Today Urology)
Source: MedPage Today Urology - August 4, 2015 Category: Urology & Nephrology Source Type: news
Morning Break: Too Old To Practice? App for Your Sex Life, Schizoid Dating
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. (Source: MedPage Today Urology)
Source: MedPage Today Urology - June 12, 2015 Category: Urology & Nephrology Source Type: news
Active Surveillance for Prostate Ca Catching On (CME/CE)
(MedPage Today) -- More than 70% of men chose surveillance as initial strategy. (Source: MedPage Today Urology)
Source: MedPage Today Urology - May 21, 2015 Category: Urology & Nephrology Source Type: news
Overactive Bladder May Set Seniors Up for a Fall (CME/CE)
(MedPage Today) -- OAD diagnosis associated with higher odds of falls in Medicare population. (Source: MedPage Today Urology)
Source: MedPage Today Urology - May 19, 2015 Category: Urology & Nephrology Source Type: news
Exercise and Cancer Risk: Cancer Network and OncoTherapy News
(MedPage Today) -- Links also discovered for diabetes and vitamin D. (Source: MedPage Today Urology)
Source: MedPage Today Urology - April 7, 2015 Category: Urology & Nephrology Source Type: news
First Penis Transplant Fully Functional
(MedPage Today) -- Three months postop, history-making procedure is deemed a success. (Source: MedPage Today Urology)
Source: MedPage Today Urology - March 13, 2015 Category: Urology & Nephrology Source Type: news
Survival Dips With Surveillance in Mid-Risk Prostate Ca
(MedPage Today) -- Still no solid algorithm to identify those who can safely go without immediate treatment. (Source: MedPage Today Urology)
Source: MedPage Today Urology - February 26, 2015 Category: Urology & Nephrology Source Type: news
Morning Break: Tricking Night Owls, Climax Count
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. (Source: MedPage Today Urology)
Source: MedPage Today Urology - December 2, 2014 Category: Urology & Nephrology Source Type: news
Kudos for RT in High-Risk Prostate Ca (CME/CE)
SAN FRANCISCO (MedPage Today) -- High-risk prostate cancer includes a subset of patients with "very high risk" characteristics that portend poor outcomes regardless of treatment, although radiotherapy led to better outcomes. (Source: MedPage Today Urology)
Source: MedPage Today Urology - September 18, 2014 Category: Urology & Nephrology Source Type: news
Morning Break: Ebola Vaccine, Baldness and Prostate Cancer
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. (Source: MedPage Today Urology)
Source: MedPage Today Urology - September 17, 2014 Category: Urology & Nephrology Source Type: news
Morning Break: Saxophone Penis, Poetry as a Drug Side Effect
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. (Source: MedPage Today Urology)
Source: MedPage Today Urology - September 15, 2014 Category: Urology & Nephrology Source Type: news
Navigating the Melanoma Landscape: The Clin Onc News Report
(MedPage Today) -- A regular update on what?s new in cancer research from our friends at Clinical Oncology News. (Source: MedPage Today Urology)
Source: MedPage Today Urology - August 5, 2014 Category: Urology & Nephrology Source Type: news
ASCO: Oreronel Fails to Boost Prostate Cancer Survival
CHICAGO (MedPage Today) -- The novel anti-androgen orteronel delayed progression in chemotherapy-naive metastatic prostate cancer refractory to standard hormone therapy, but without a survival benefit. (Source: MedPage Today Urology)
Source: MedPage Today Urology - June 5, 2014 Category: Urology & Nephrology Source Type: news
